This project is part of the EDCTP3 programme supported by the European Union

SAFIRE funders

The 4.5-year SAFIRE project, which runs from June 2024 to November 2028, is funded by the European and Developing Countries Clinical Trials Partnership (EDCTP3), the European Union and the Swiss State Secretariat for Education, Research and Innovation (SERI).

Quality of information disclaimer: Funded by the European Union, under the Global Health EDCTP3 Joint Undertaking. Views and opinions expressed are; however, those of the author(s) only and do not necessarily reflect those of Global Health EDCTP3 nor its members. Neither of the aforementioned parties can be held responsible for them.

Linkedin-in

Subscribe to the SAFIRE newsletter

* indicates required

Please select all the ways you would like to hear from :

You can unsubscribe at any time by clicking the link in the footer of our emails. For information about our privacy practices, please visit our website.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.